Sievers Eric's Form 4 filing
BioAtla, Inc. (BCAB) · filed Dec 6, 2021
- Accession no.
- 0001209191-21-068212
- Filed
- Dec 6, 2021
- Trade date
- Nov 29, 2021
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $2.63K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sievers EricCIK 0001835116 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2021 | Common Stock | SSaleDisposed | −110 | $23.89F2 | −$2,627.9 | 92,630 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The range of prices for the shares of Common Stock is from $23.75 to $24.11. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
Referenced by the price of 1 transaction in Table I.